Pier F. Porceddu

Via Ospedale 72
Cagliari, 09124, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Inhibition of N-acylethanolamine-hydrolyzing acid amidase reduces T cell infiltration in a mouse model of multiple sclerosis.

Inhibition of N-acylethanolamine-hydrolyzing acid amidase reduces T cell infiltration in a mouse model of multiple sclerosis.

Journal: Pharmacological research

Published: June 14, 2021

The novel potent GSK3 inhibitor AF3581 reverts fragile X syndrome phenotype.

The novel potent GSK3 inhibitor AF3581 reverts fragile X syndrome phenotype.

Journal: Human molecular genetics

Published: May 23, 2021

Novel fragile X syndrome 2D and 3D brain models based on human isogenic FMRP-KO iPSCs.

Novel fragile X syndrome 2D and 3D brain models based on human isogenic FMRP-KO iPSCs.

Journal: Cell death & disease

Published: November 19, 2020

The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor.

The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: January 22, 2020

Optimization of Indazole-Based GSK-3 Inhibitors with Mitigated hERG Issue and In Vivo Activity in a Mood Disorder Model.

Optimization of Indazole-Based GSK-3 Inhibitors with Mitigated hERG Issue and In Vivo Activity in a Mood Disorder Model.

Journal: ACS medicinal chemistry letters

Published: December 20, 2019

Lack of Rhes Increases MDMA-Induced Neuroinflammation and Dopamine Neuron Degeneration: Role of Gender and Age.

Lack of Rhes Increases MDMA-Induced Neuroinflammation and Dopamine Neuron Degeneration: Role of Gender and Age.

Journal: International journal of molecular sciences

Published: February 15, 2019

Rhes Counteracts Dopamine Neuron Degeneration and Neuroinflammation Depending on Gender and Age.

Rhes Counteracts Dopamine Neuron Degeneration and Neuroinflammation Depending on Gender and Age.

Journal: Frontiers in aging neuroscience

Published: February 22, 2018

Widespread reduction of dopamine cell bodies and terminals in adult rats exposed to a low dose regimen of MDMA during adolescence.

Widespread reduction of dopamine cell bodies and terminals in adult rats exposed to a low dose regimen of MDMA during adolescence.

Journal: Neuropharmacology

Published: February 21, 2017

Effect of crowding, temperature and age on glia activation and dopaminergic neurotoxicity induced by MDMA in the mouse brain.

Effect of crowding, temperature and age on glia activation and dopaminergic neurotoxicity induced by MDMA in the mouse brain.

Journal: Neurotoxicology

Published: April 22, 2016

Novel (Hetero)arylalkenyl propargylamine compounds are protective in toxin-induced models of Parkinson's disease.

Novel (Hetero)arylalkenyl propargylamine compounds are protective in toxin-induced models of Parkinson's disease.

Journal: Molecular neurodegeneration

Published: August 25, 2015

Metformin Prevented Dopaminergic Neurotoxicity Induced by 3,4-Methylenedioxymethamphetamine Administration.

Metformin Prevented Dopaminergic Neurotoxicity Induced by 3,4-Methylenedioxymethamphetamine Administration.

Journal: Neurotoxicity research

Published: August 21, 2015

Influence of caffeine on 3,4-methylenedioxymethamphetamine-induced dopaminergic neuron degeneration and neuroinflammation is age-dependent.

Influence of caffeine on 3,4-methylenedioxymethamphetamine-induced dopaminergic neuron degeneration and neuroinflammation is age-dependent.

Journal: Journal of neurochemistry

Published: July 01, 2015

Showing 1-12 of 13

Last Updated: 09/26/2026